Tobramycin is a amino cyclitol glycoside that is kanamycin B lacking the 3-hydroxy substituent from the 2,6-diaminoglucose ring. Among its listed roles, it functions as a antibacterial agent, an antimicrobial agent and a toxin. Functionally, it is related to kanamycin B. It is the conjugate base of tobramycin. It is grouped under the following drug class(es): Aminoglycosides. Its therapeutic use is listed as anti-infectives, antibacterials, antibiotics and ophthalmic agents. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Nebramycin VI, Nebramycin 6, Obramycin, Bethkis and Kitabis Pak. Its PubChem CID is 36294.
Tobramycin
| CAS No | 32986-56-4 |
|---|---|
| Molecular Formula | C18H37N5O9 |
| Molecular Weight | 467.5 g/mol |
| Synonyms | (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tobramycin is a amino cyclitol glycoside that is kanamycin B lacking the 3-hydroxy substituent from the 2,6-diaminoglucose ring. Among its listed roles, it functions as a antibacterial agent, an antimicrobial agent and a toxin.
The listed CAS number is 32986-56-4.
The listed molecular formula is C18H37N5O9.
The listed molecular weight is 467.5 g/mol.
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol.
The source lists Nebramycin VI, Nebramycin 6, Obramycin, Bethkis and Kitabis Pak.